CARCIVOR is used either:- Alone, to treat postmenopausal women with a type of breast cancer called estrogen receptor positive breast cancer that is locally advanced or has spread to other parts of the body (metastatic), or- In combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, that is locally advanced or has spread to other parts of the body (metastatic). Women who have not reached menopause will also be treated with a medicine called a luteinizing hormone releasing hormone (LHRH) agonist.

to treat prostate cancer in adult men that has spread to other parts of the body

to treat prostate cancer in adult men that has spread to other parts of the body

Remosta is used to treat adults with the following types of cancer:- Gastrointestinal stromal tumour (GIST), a type of cancer of the stomach and bowel, where imatinib (another anticancer medicine) no longer works or you cannot take imatinib.- Metastatic renal cell carcinoma (MRCC), a type of kidney cancer that has spread to other parts of the body.- Pancreatic neuroendocrine tumours (pNET) (tumours of the hormone-producing cells in the pancreas) that have progressed or cannot be removed with surgery.

Remosta is used to treat adults with the following types of cancer:- Gastrointestinal stromal tumour (GIST), a type of cancer of the stomach and bowel, where imatinib (another anticancer medicine) no longer works or you cannot take imatinib.- Metastatic renal cell carcinoma (MRCC), a type of kidney cancer that has spread to other parts of the body.- Pancreatic neuroendocrine tumours (pNET) (tumours of the hormone-producing cells in the pancreas) that have progressed or cannot be removed with surgery.

Remosta is used to treat adults with the following types of cancer:- Gastrointestinal stromal tumour (GIST), a type of cancer of the stomach and bowel, where imatinib (another anticancer medicine) no longer works or you cannot take imatinib.- Metastatic renal cell carcinoma (MRCC), a type of kidney cancer that has spread to other parts of the body.- Pancreatic neuroendocrine tumours (pNET) (tumours of the hormone-producing cells in the pancreas) that have progressed or cannot be removed with surgery.

for the treatment of multiple myeloma (a cancer of the bone marrow) in patients older than 18 years

used to control your body’s immune response enabling your body to accept the transplanted organ.

used to control your body’s immune response enabling your body to accept the transplanted organ.

used to reduce the number of times you suffer attacks of multiple sclerosis (relapses).

used to reduce the number of times you suffer attacks of multiple sclerosis (relapses).

used to control your body’s immune response enabling your body to accept the transplanted organ.